Company news

Mayne Pharma Group Ltd. news in 2017

Mayne Pharma Group Ltd.'s news releases, calls and decks from 2017, newest first.

View company

2017 CEOs Speech

November 27, 2017

Mayne Pharma launches clozapine tablets in the US

November 8, 2017

Mayne Pharma adds two products to its Australian portfolio

September 14, 2017

FDA approval and first generic launch of Acticlate tablets

June 14, 2017

Clarification statement

May 2, 2017

Mayne Pharma acquires rights to generic Duragesic in the US

March 8, 2017

License and supply agreement for generic Nuvaring in the US

February 27, 2017

2017 Half Year Media Release

February 23, 2017

Mayne Pharma launches Butalbital / APAP tablets in the US

February 15, 2017

Mayne Pharma launches Amiodarone 100mg tablets

January 12, 2017

Mayne Pharma launches Fabior and Sorilux in the US

January 10, 2017

Decks in 2017